PPT-Overview of Challenges in the Conduct of Interventional Trials to Address Antibacterial
Author : deborah | Published Date : 2024-01-29
21 Jan 2016 Symposium New Frontiers in Antibacterial Resistance Research John H Rex MD 20160121 AMR Research Frontiers Challenge of clinical studies 1 Senior VP
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Overview of Challenges in the Conduct of..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Overview of Challenges in the Conduct of Interventional Trials to Address Antibacterial: Transcript
21 Jan 2016 Symposium New Frontiers in Antibacterial Resistance Research John H Rex MD 20160121 AMR Research Frontiers Challenge of clinical studies 1 Senior VP and Chief Strategy Officer AstraZeneca Antibiotics Business Unit NonExecutive Director F2G Ltd and . New. Novel. Antibacterials?. How Difficult Is It to Discover New Antibacterials?. Lynn L. Silver, Ph.D.. LL Silver Consulting, LLC. Antibacterials at FDA 2000-2011. Compound. Usage. Class . Active versus . Elliot Young. Honey. Background. Background. Background. Background. Background. +. Background. Methodology. 3 honeys compared:. Processed. Unprocessed. 10+ UMF Manuka. Honey’s antibacterial qualities tested against . and . Machine Learning. Michael Charlton. ChEMBL. Physical Property Analysis. Ebejer. . et al.. (J. Cheminformatics) extracted data from . Chembl. and assigned an anti-bacterial class. Antibacterial . New. Novel. Antibacterials?. How Difficult Is It to Discover New Antibacterials?. Lynn L. Silver, Ph.D.. LL Silver Consulting, LLC. Antibacterials at FDA 2000-2011. Compound. Usage. Class . Active versus . % . survivors. Penicillin. Untreated. Days. Penicillin increased the chance of survival from 10% to 90%. Patients with. pneumonia . and bacteria . in the blood. Adapted from Austrian . et al.. Ann. Int. Med 1964; . Susan S. . Ellenberg. , Ph.D.. University of Pennsylvania. SCT/ICTMC Joint Meeting. Liverpool, UK. May 8, 2017. CLINICAL TRIALS TIMELINE. 1948: First randomized clinical trials of modern era. 1962: Amendments to U.S. Food, Drug and Cosmetic Act requiring demonstration of efficacy as well as safety. The . Clinical and Economic Value . of . an IR Practice. IR Is Modern Medicine. Through a tiny incision in the skin, interventional radiologists deliver precise, targeted treatment . Life-threatening conditions — such as cardiovascular disease, stroke or cancer — are treated less invasively than . % . survivors. Penicillin. Untreated. Days. Penicillin increased the chance of survival from 10% to 90%. Patients with. pneumonia . and bacteria . in the blood. Adapted from Austrian . et al.. Ann. Int. Med 1964; . Prof.. Nader . Alaridah. Antibacterial therapy. 2000 B.C. - "Here, eat this root.". 1000 B.C. - "That root is heathen, say this prayer.". 1850 A.D. - "That prayer is superstition, drink this potion.". CLINICAL TRIALS IN THE TWENTY-FIRST CENTURY: ONGOING CHALLENGES AND EMERGING ISSUES Susan S. Ellenberg , Ph.D. University of Pennsylvania SCT/ICTMC Joint Meeting Liverpool, UK May 8, 2017 CLINICAL TRIALS TIMELINE RADIOLOGY70 Dubois Street Newburgh NY 12550845 568-2242 WWWSTLUKESCORNWALLHOSPITALORGDr Chris Donikyan Interventional RadiologistHighlytrainedExperiencedBoardCert VERSION 1 AUGUST 2016DEVELOPED AND EDITED BYKyle J Cooper MD Minhaj S Khaja MD MBA Sravanthi Reddy MD Kate Klein MDWITH HELP AND INPUT FROM OTHER AMSER MEMBERS INTRODUCTION This document is intended Speaker. : [ ]. Date: [ ]. Venue: [ ]. A presentation by . the Canadian Association for Interventional Radiology . (. CAIR). http://www.medicine.dal.ca/departments/department-sites/radiology.html. Real life case. Table of ContentsPreamble ...............................................................................................................................................1Commitment to Protecting Resea
Download Document
Here is the link to download the presentation.
"Overview of Challenges in the Conduct of Interventional Trials to Address Antibacterial"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents